ArticleBlood cancer discovery2023

Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches.

Pramod C Nair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.